Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on October 6, 2026

Oct. 6, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

Indeterminate GlobeNewswire

Oct. 6, 2026

Nayax Enters US Fuel Retail Through Distribution Partnership with Allied Electronics, Inc.

Indeterminate GlobeNewswire

Oct. 6, 2026

First Atlantic Nickel & Cobalt Raises Total of $13.4 Million with Additional $3.49 Million No-Warrant, Non-Brokered Private Placement at $0.83 per Share, a Premium to Market, to Accelerate Exploration at Pipestone XL Nickel-Cobalt Alloy Project

Indeterminate GlobeNewswire

Oct. 6, 2026

STARTRADER Adds 20 Stock and ETF CFDs to Its 24/7 Trading Range

Indeterminate GlobeNewswire

Oct. 6, 2026

Zenas BioPharma to Host Virtual R&D Event

Indeterminate GlobeNewswire

Oct. 6, 2026

LiveU and Airwise Announce Strategic Partnership to Deliver End-to-End Solution for Public Safety Situational Awareness

Indeterminate GlobeNewswire

Oct. 6, 2026

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

Indeterminate GlobeNewswire

Oct. 6, 2026

Shopify to Announce Third-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Oct. 6, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)

Indeterminate GlobeNewswire

Oct. 6, 2026

OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain

Indeterminate GlobeNewswire

Oct. 6, 2026

MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics

Indeterminate GlobeNewswire

Oct. 6, 2026

GTC Prime Partners with Centroid Solutions to Deliver Multi-Asset Liquidity via CS 360 Bridge

Indeterminate GlobeNewswire

Oct. 6, 2026

Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy

Indeterminate GlobeNewswire

Oct. 6, 2026

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Indeterminate GlobeNewswire

Oct. 6, 2026

Newcore Gold Drilling Intersects 1.16 g/t Gold over 41.0 Metres, Including 2.54 g/t Gold over 13.0 Metres, at the Enchi Gold Project, Ghana

Indeterminate GlobeNewswire

Oct. 6, 2026

PropLaunch Joins Forces with Axcera and RUBIK to Help Founders Launch Prop Firms

Indeterminate GlobeNewswire

Oct. 6, 2026

HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA

Indeterminate GlobeNewswire

Oct. 6, 2026

RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01

Indeterminate GlobeNewswire

Oct. 6, 2026

Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Oct. 6, 2026

RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire